Swiss Biotech Stock News

Dividend increase as a fresh signal for EPIC Suisse EPIC Suisse (SWX:EPIC) recently received shareholder approval at its 10 April 2026 AGM for a higher dividend of CHF 3.20 per share for the 2025 business year, payable on 21 April 2026. This decision places income returns at the center of the story for this Swiss real estate owner and manager. It also gives investors a fresh reference point for weighing the stock’s recent price performance and income profile. See our latest analysis for EPIC...

With the business potentially at an important milestone, we thought we'd take a closer look at Peach Property Group...

Amrize (SWX:AMRZ) has caught investor attention after a recent price move, with the share closing at CHF 46.0. This development puts the focus on how its building solutions business is currently positioned. See our latest analysis for Amrize. The recent CHF 46.0 share price sits against a 1 month share price return of 9.9% and a 3 month share price return of 9.5%. This suggests short term momentum has picked up, while year to date gains remain more modest at 3.4%. If this move has you...

Comet Holding (SWX:COTN) has drawn attention after reporting first quarter 2026 net sales of CHF 106.3 million, a 4.5% year on year decline, while reaffirming guidance that full year net sales should significantly exceed 2025. See our latest analysis for Comet Holding. The share price has moved sharply higher in recent weeks, with a 30.1% year to date share price return and a 53.7% total shareholder return over the past year. This suggests momentum has been building as investors react to the...

Helvetia Baloise Holding AG recently reported full-year 2025 results, with net income of CHF 552.3 million and basic earnings per share of CHF 10.32, and also approved an annual dividend of CHF 7.70 per share payable on May 29, 2026. The combination of higher earnings and an increased cash return through the dividend offers fresh insight into how Helvetia Baloise is allocating capital between shareholder payouts and ongoing growth initiatives. We’ll now examine how the stronger full-year...

As European markets experience a positive momentum, with the STOXX Europe 600 Index rising by 1.91% amid favorable corporate earnings and geopolitical developments, investors are increasingly focused on identifying stocks that may be trading below their intrinsic value. In such an environment, finding undervalued stocks involves assessing companies with strong fundamentals that may have been overlooked or mispriced by the market, offering potential opportunities for long-term growth despite...

ABB recently secured a contract to supply gearless mill drive and ring-geared mill drive systems for the Eva Copper Mine Project in Queensland, Australia, aiming to boost grinding efficiency, reliability and operational flexibility for the copper concentrator. This mining technology win highlights ABB’s role in enabling the energy transition through critical-minerals projects that increasingly demand efficient, low-risk processing solutions. We’ll now examine how winning a major copper mine...

Barry Callebaut (SWX:BARN) has come back into focus after forming a Growth Accelerator Coalition and outlining a tighter set of priorities, along with tactical reinvestments following earlier operational disruptions that weighed on volumes. See our latest analysis for Barry Callebaut. That renewed focus comes after a sharp reset in sentiment, with a 7 day share price return of an 18.36% decline and a 30 day share price return of a 19.75% decline. Even though the 1 year total shareholder...

Chocoladefabriken Lindt & Sprüngli (SWX:LISN) has launched its Lindt EXCELLENCE Fusion line, a layered dark and milk or white chocolate bar aimed at widening appeal among consumers who find pure dark chocolate too intense. See our latest analysis for Chocoladefabriken Lindt & Sprüngli. At a share price of CHF107,000.0, the 1 day share price return of 1.90% comes after a weaker patch, with a 90 day share price return showing a 6.63% decline and a 1 year total shareholder return showing a 7.04%...

UBS Group (SWX:UBSG) is in focus after Chairman Colm Kelleher warned that proposed Swiss capital rules could leave the bank as an international outlier and force difficult choices about future business priorities. See our latest analysis for UBS Group. The share price has moved up to CHF34.45, with a 1 month share price return of 15.14% and a 7 day gain of 5.29%. However, the 90 day share price return is a 9.39% decline and the year to date share price return is a 9.75% decline. At the same...

Implenia (SWX:IMPN) has secured a contract exceeding €200 million to plan and build the new Münster police headquarters in Germany, a long-dated project with completion targeted for October 2029. See our latest analysis for Implenia. The contract news arrives after a mixed period for the stock, with the share price at CHF66.8 and a year-to-date share price return showing a decline of 15.44%, but a 1-year total shareholder return of 56.24%, suggesting that long-term momentum remains stronger...

If you are wondering whether Alcon's current share price still reflects good value or if the market has already priced in the story, this article walks through the key numbers so you can judge that for yourself. Alcon shares last closed at US$63.90, with returns of 3.7% over the past week, 6.7% over the last 30 days and 0.6% year to date, while the 1 year return stands at a 14.9% decline. Recent headlines around Alcon have focused on its position in eye care and medical equipment, along with...

Last week, SHL Telemedicine Ltd. ( VTX:SHLTN ) insiders, who had purchased shares in the previous 12 months were...

Novartis (SWX:NOVN) CEO Vas Narasimhan has joined the board of AI company Anthropic, marking the first time a major pharmaceutical chief executive has taken a board role at a leading artificial intelligence startup. Novartis is expanding global health and community outreach programs, targeting improved cancer and cardiovascular disease outcomes in over 30 countries by 2030. The company is also advancing late-stage therapies for myasthenia gravis, adding another area of focus to its...

Helvetia Baloise Holding (SWX:HBAN) has drawn fresh attention after reporting full year 2025 earnings and confirming an annual dividend of CHF 7.70 per share, scheduled for payment on May 29, 2026. See our latest analysis for Helvetia Baloise Holding. The 11.09% 30 day share price return, together with a 27.50% 1 year total shareholder return and a latest share price of CHF 222.40, indicates that momentum has been building around the recent earnings and dividend announcement. If these...

AI driven beauty launch puts Givaudan (SWX:GIVN) in focus Givaudan Active Beauty’s partnership with Haut.AI to showcase AI powered ingredient simulations at in cosmetics Global 2026 is drawing fresh attention to how the business connects scientific claims with consumer facing experiences. See our latest analysis for Givaudan. At a share price of CHF2,964.0, Givaudan has seen short term momentum pick up, with a 1 month share price return of 6.66% and 7 day gain of 5.56%. However, the 1 year...

Nestlé (SWX:NESN) is under scrutiny after the Teamsters union accused the company of anti union activity in several US facilities, raising fresh questions about its labor practices and broader corporate responsibility. See our latest analysis for Nestlé. Recent news around labor disputes and a possible exit from parts of the ice cream business comes as Nestlé’s share price edges higher, with a 90 day share price return of 5.02% but a 3 year total shareholder return decline of 25.43%,...

Investors in Burkhalter Holding AG ( VTX:BRKN ) had a good week, as its shares rose 7.9% to close at CHF184 following...

Wondering whether ABB at CHF 72.44 is priced for perfection or still offers value? This article walks you through what the current market price may be implying. The stock has posted returns of 2.3% over 7 days, 8.8% over 30 days, 18.3% year to date and 74.2% over 1 year, with a 3 year return of 142.6% and 5 year return of 185.3% that many investors will be weighing against the current valuation. Recent attention on ABB has centered on how its share price performance and business profile fit...

If you are wondering whether Amrize, at a last close of CHF45.16, still offers value or if the easy gains are gone, this article walks you through what the current price might really imply. The stock has recently posted returns of 0.9% over 7 days, 2.3% over 30 days and 1.5% year to date. This naturally raises questions about how much of its potential is already reflected in the price. Recent coverage of Amrize has focused on providing investors with evergreen context around the company and...

It looks like UBS Group AG ( VTX:UBSG ) is about to go ex-dividend in the next three days. The ex-dividend date is...

It looks like Flughafen Zürich AG ( VTX:FHZN ) is about to go ex-dividend in the next three days. The ex-dividend date...

Recent share performance and business scale Novartis (SWX:NOVN) has recently seen a 0.8% decline over the past day and a 3.9% decline over the past week, with the share price closing at CHF 117.42. Over the past month the stock shows a 3.6% decline, while the past 3 months reflect a 1.6% total return and the past year a 33.5% total return. Measured over 5 years, the total return stands at 83.6%. The company reports annual revenue of $56.7b and net income of $14.0b, with both revenue and net...

Barry Callebaut (SWX:BARN) has released its H1 2026 scorecard with Total Revenue of CHF 7.5b and Basic EPS of CHF 28.03 in the second half of 2025, alongside CHF 7.3b of revenue and EPS of CHF 5.85 in the first half. Trailing twelve month EPS stands at CHF 33.90 on CHF 14.8b of revenue, framing the latest read on profitability. The company’s Total Revenue has increased from CHF 5.7b and EPS of CHF 20.40 in H2 2024 to the current H2 2025 levels, drawing investor attention to how slim margins...